[Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma].
Maiia SolovevaL P MendeleevaElena N ParovichnikovaM V SolovevLarisa A KuzminaNatalya RisinskayaT V AbramovaIrina Vladimirovna GaltsevaS M KulikovPublished in: Terapevticheskii arkhiv (2021)
Allo-HSCT is considered as an alternative method of therapy for young patients with aggressive MM. Allo-HSCT in MM in some cases leads to long-term immunological control of the tumor.